RHOA and nonpapillary renal cell carcinoma: The protective effect of simvastatin was also observed in Caki-2 cells (a ccRCC cell line) and was indicated by an increase in the active form of RhoA in the membrane and a decrease in membrane-bound CD44 (Fig. 2e).